{"bill":{"bill_id":1264535,"change_hash":"aca8fd015f57349b6a916d859ca6fa29","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB1662\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/1662\/all-info","completed":0,"status":1,"status_date":"2019-05-23","progress":[{"date":"2019-05-23","event":1},{"date":"2019-05-23","event":9}],"state":"US","state_id":52,"bill_number":"SB1662","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"Opioid Treatment Surge Act","description":"Requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.","pending_committee_id":2328,"committee":{"committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"},"referrals":[{"date":"2019-05-23","committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"}],"history":[{"date":"2019-05-23","action":"Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9469,"person_hash":"58q1t500","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Jeff Merkley","first_name":"Jeff","middle_name":"","last_name":"Merkley","suffix":"","nickname":"","district":"SD-OR","ftm_eid":13005237,"votesmart_id":23644,"opensecrets_id":"N00029303","knowwho_pid":198129,"ballotpedia":"Jeff_Merkley","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"HB3105","sast_bill_id":1266953}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13307,"subject_name":"Drug, alcohol, tobacco use"},{"subject_id":13207,"subject_name":"Health care coverage and access"},{"subject_id":13490,"subject_name":"Prescription drugs"},{"subject_id":13648,"subject_name":"User charges and fees"}],"texts":[{"doc_id":2033997,"date":"2019-06-05","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB1662\/id\/2033997","state_link":"https:\/\/www.congress.gov\/116\/bills\/s1662\/BILLS-116s1662is.pdf","text_size":245044,"text_hash":"0da52237fe99a1b595eeba4175784b6b"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}